HIMS Hims Hers Health Inc

$44.56

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending —
Expected on —
Report Time: Unknown Release Time
The Whisper Number
—
Consensus Estimate: —
Revenue Estimate: —

Latest Earnings Insight

Updated On 8/22/2025

About Hims Hers Health Inc

Hims & Hers Health, Inc. operates a multi-specialty telehealth platform that connects consumers with licensed healthcare professionals. The company is headquartered in San Francisco, California.

Website: https://www.hims.com

Sector
REAL ESTATE & CONSTRUCTION
Industry
BLANK CHECKS
Exchange
NYSE
Country
USA
Currency
USD
Fiscal Year End
December
CIK
1773751
Address
333 S. GRAND AVE., 28TH FLOOR, LOS ANGELES, CA, US
Valuation
Market Cap
$6.05B
P/E Ratio
51.38
PEG Ratio
2.57
Price to Book
12.69
Performance
EPS
$0.53
Dividend Yield
—
Profit Margin
8.54%
ROE
30.70%
Technicals
50D MA
$37.83
200D MA
$26.52
52W High
$72.98
52W Low
$11.20
Fundamentals
Shares Outstanding
214M
Target Price
$44.82
Beta
1.66

HIMS EPS Estimates vs Actual

● Estimated
● Actual

HIMS News & Sentiment

Aug 22, 2025 • Benzinga NEUTRAL
DEADLINE ALERT for HIMS, IRBT, CNC, BHVN: Law Offices of Howard G. Smith Reminds Investors of Opportunity to Lead Securities Fraud Class Actions - Biohaven ( NYSE:BHVN ) , Centene ( NYSE:CNC )
BENSALEM, Pa., Aug. 22, 2025 ( GLOBE NEWSWIRE ) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the deadlines listed below to file a lead plaintiff motion.
Aug 22, 2025 • Benzinga NEUTRAL
MONDAY DEADLINE: Berger Montague Advises Hims & Hers Health Inc. ( NYSE: HIMS ) Investors to Inquire About a Securities Fraud Class Action by August 25, 2025 - Hims & Hers Health ( NYSE:HIMS )
PHILADELPHIA, Aug. 22, 2025 ( GLOBE NEWSWIRE ) -- Berger Montague, a national securities litigation law firm, is investigating potential securities fraud claims against Hims & Hers Health Inc. ( "Hims & Hers" or the "Company" ) ( NYSE:HIMS ) .
Aug 22, 2025 • Zacks Commentary SOMEWHAT-BULLISH
Is Trending Stock Hims & Hers Health, Inc. ( HIMS ) a Buy Now?
Zacks.com users have recently been watching Hims & Hers Health (HIMS) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Aug 22, 2025 • Benzinga SOMEWHAT-BULLISH
HIMS FINAL DEADLINE: ROSEN, A TOP RANKED LAW FIRM, Encourages Hims & Hers Health, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important August 25 Deadline in Securities Class Action - HIMS - ( HIMS )
NEW YORK, Aug. 21, 2025 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Hims & Hers Health, Inc. HIMS between April 29, 2025 and June 23, 2025, both dates inclusive ( the "Class Period" ) , of the important August 25, 2025 ...
Aug 21, 2025 • Benzinga NEUTRAL
The Gross Law Firm Reminds Hims & Hers Health, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of August 25, 2025 - HIMS - Hims & Hers Health ( NYSE:HIMS )
NEW YORK, Aug. 21, 2025 ( GLOBE NEWSWIRE ) -- The Gross Law Firm issues the following notice to shareholders of Hims & Hers Health, Inc. HIMS. Shareholders who purchased shares of HIMS during the class period listed are encouraged to contact the firm regarding possible lead plaintiff ...
Aug 21, 2025 • Motley Fool BULLISH
Got $5,000? 3 Tech Stocks to Buy and Hold for the Long Term
Autodesk, Hims & Hers Health, and Affirm are attractive technology stocks to add to your growth stock portfolio.
Sentiment Snapshot

Average Sentiment Score:

0.091
50 articles with scored sentiment

Overall Sentiment:

Neutral

HIMS Reported Earnings

Feb 24, 2025
Dec 31, 2024 (Post market)
0.01 Surprise
  • Reported EPS: $0.23
  • Estimate: $0.22
  • Whisper: —
  • Surprise %: 4.2%
Nov 04, 2024
Sep 30, 2024 (Post market)
0.28 Surprise
  • Reported EPS: $0.32
  • Estimate: $0.04
  • Whisper: —
  • Surprise %: 700.0%
Aug 05, 2024
Jun 30, 2024 (Post market)
0.02 Surprise
  • Reported EPS: $0.06
  • Estimate: $0.04
  • Whisper: —
  • Surprise %: 50.0%
May 06, 2024
Mar 31, 2024 (Post market)
0.04 Surprise
  • Reported EPS: $0.05
  • Estimate: $0.01
  • Whisper: —
  • Surprise %: 400.0%
Feb 26, 2024
Dec 31, 2023 (Post market)
0.03 Surprise
  • Reported EPS: $0.01
  • Estimate: $-0.02
  • Whisper: —
  • Surprise %: 150.0%
Nov 06, 2023
Sep 30, 2023 (Post market)
-0.01 Surprise
  • Reported EPS: $-0.04
  • Estimate: $-0.03
  • Whisper: —
  • Surprise %: -33.3%
Aug 07, 2023
Jun 30, 2023 (Post market)
0.02 Surprise
  • Reported EPS: $-0.03
  • Estimate: $-0.05
  • Whisper: —
  • Surprise %: 40.0%
May 08, 2023
Mar 31, 2023 (Post market)
0.02 Surprise
  • Reported EPS: $-0.05
  • Estimate: $-0.07
  • Whisper: —
  • Surprise %: 28.6%
Feb 27, 2023
Dec 31, 2022 (Post market)
0.02 Surprise
  • Reported EPS: $-0.05
  • Estimate: $-0.07
  • Whisper: —
  • Surprise %: 28.6%

Financials